Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,586
Closed -$277K 322
2025
Q3
$277K Sell
8,586
-24
-0.3% -$777 0.01% 261
2025
Q2
$294K Buy
8,610
+10
+0.1% +$328 0.01% 258
2025
Q1
$265K Sell
8,600
-448
-5% -$14.5K 0.01% 250
2024
Q4
$286K Buy
9,048
+427
+5% +$14K 0.01% 239
2024
Q3
$282K Buy
8,621
+35
+0.4% +$1.02K 0.01% 242
2024
Q2
$227K Sell
8,586
-112
-1% -$2.98K 0.01% 261
2024
Q1
$246K Sell
8,698
-98
-1% -$2.63K 0.01% 282
2023
Q4
$225K Sell
8,796
-271
-3% -$6.85K 0.01% 277
2023
Q3
$220K Buy
9,067
+267
+3% +$7.63K 0.01% 263
2023
Q2
$259K Hold
8,800
0.01% 247
2023
Q1
$236K Hold
8,800
0.01% 249
2022
Q4
$274K Buy
8,800
+214
+2% +$6.11K 0.01% 223
2022
Q3
$209K Hold
8,586
0.01% 247
2022
Q2
$216K Hold
8,586
0.01% 254
2022
Q1
$250K Hold
8,586
0.01% 241
2021
Q4
$225K Hold
8,586
0.01% 255
2021
Q3
$203K Hold
8,586
0.01% 226
2021
Q2
$219K Buy
+8,586
New +$200K 0.01% 223
2021
Q1
Sell
-54,514
Closed -$984K 203
2020
Q4
$984K Buy
54,514
+3,758
+7% +$65.5K 0.07% 101
2020
Q3
$881K Buy
50,756
+1,398
+3% +$25.8K 0.07% 106
2020
Q2
$1.02M Buy
49,358
+1,275
+3% +$22.4K 0.1% 78
2020
Q1
$676K Buy
48,083
+163
+0.3% +$2.43K 0.07% 104
2019
Q4
$804K Buy
47,920
+837
+2% +$14K 0.07% 106
2019
Q3
$780K Buy
47,083
+3,412
+8% +$54.8K 0.07% 120
2019
Q2
$769K Buy
43,671
+1,887
+5% +$36.1K 0.06% 128
2019
Q1
$807K Buy
41,784
+98
+0.2% +$2.03K 0.07% 127
2018
Q4
$704K Buy
41,686
+8,941
+27% +$164K 0.05% 126
2018
Q3
$783K Buy
32,745
+242
+0.7% +$6.09K 0.07% 122
2018
Q2
$812K Sell
32,503
-2,242
-6% -$55.6K 0.07% 121
2018
Q1
$714K Buy
+34,745
New +$748K 0.06% 125
2017
Q4
Sell
-34,822
Closed -$673K 96
2017
Q3
$673K Sell
34,822
-534
-2% -$10K 0.06% 127
2017
Q2
$645K Buy
35,356
+5,298
+18% +$95.5K 0.06% 133
2017
Q1
$490K Buy
+30,058
New +$508K 0.04% 149

Other funds holding BOX

Aspiriant LLC's BOX Position: Q4 2025 in Review

Aspiriant LLC sold out of Box (BOX) in Q4 2025, closing a stake of 8,586 shares — an estimated $277K sold.

Aspiriant LLC first reported a position in BOX in Q1 2017 and held it in 33 quarters. The position peaked at $1.02M in Q2 2020. 412 funds tracked by Wall St. Rank hold BOX as of Q4 2025.

  • Aspiriant LLC reported no remaining Box position as of Q4 2025 after selling out during the quarter.
  • Aspiriant LLC sold 8,586 Box shares in Q4 2025, an estimated $277K.
  • Aspiriant LLC first reported a position in Box in Q1 2017 and held it in 33 quarters.
  • Aspiriant LLC's Box position peaked at $1.02M in Q2 2020.
  • 412 funds tracked by Wall St. Rank held Box as of Q4 2025.

Based on Aspiriant LLC's 13F filing for Q4 2025, filed 20 Jan 2026.